Evaluation of nephrotic syndrome

Nishi S, Ubara Y, Utsunomiya Y, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016 Jun;20(3):342-70.Full text  Abstract

Trautmann A, Boyer O, Hodson E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023 Mar;38(3):877-919.Full text  Abstract

Kidney Disease Improving Global Outcomes Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021 Oct;100(4S):1-276.Full text

1. Müller-Deile J, Sarau G, Kotb AM, et al. Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis. Sci Rep. 2021 Feb 25;11(1):4577.Full text  Abstract

2. Pozdzik A, Brochériou I, David C, et al. Membranous nephropathy and anti-podocytes antibodies: implications for the diagnostic workup and disease management. Biomed Res Int. 2018 Jan;2018:6281054.Full text  Abstract

3. Sadowski CE, Lovric S, Ashraf S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015 Jun;26(6):1279-89.Full text  Abstract

4. Wheeler DC. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins. J Nephrol. Nov-Dec 2001;14(suppl 4):S70-5. Abstract

5. Gigante A, Barbano B, Sardo L, et al. Hypercoagulability and nephrotic syndrome. Curr Vasc Pharmacol. 2014 May;12(3):512-7. Abstract

6. Barbano B, Gigante A, Amoroso A, et al. Thrombosis in nephrotic syndrome. Semin Thromb Hemost. 2013 Jul;39(5):469-76. Abstract

7. Remuzzi G, Mecca G, Marchesi D, et al. Platelet hyperaggregability and the nephrotic syndrome. Thromb Res. 1979;16(3-4):345-54. Abstract

8. Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int. 2002 Oct;62(4):1379-84.Full text  Abstract

9. Kim SW, Frokiaer J, Nielsen S. Pathogenesis of oedema in nephrotic syndrome: role of epithelial sodium channel. Nephrology (Carlton). 2007 Dec;12(suppl 3):S8-10. Abstract

10. Wong ZY, Teo CY, Fiona Wong YQ, et al. Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: a systematic review and meta-analysis. PLoS One. 2024 Jul 31;19(7):e0307981.Full text  Abstract

11. Nishi S, Ubara Y, Utsunomiya Y, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016 Jun;20(3):342-70.Full text  Abstract

12. Londeree J, McCracken CE, Greenbaum LA, et al. Estimation of childhood nephrotic syndrome incidence: data from the atlanta metropolitan statistical area and meta-analysis of worldwide cases. J Nephrol. 2022 Mar;35(2):575-83. Abstract

13. van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011 Jun;26(6):881-92. Abstract

14. Zhang S, Audard V, Fan Q, et al. Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol. 2011;169:94-106. Abstract

15. Gbadegesin R, Lavin P, Foreman J, et al. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol. 2011 Jul;26(7):1001-15. Abstract

16. Elie V, Fakhoury M, Deschênes G, et al. Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol. 2012 Aug;27(8):1249-56. Abstract

17. El Bakkali L, Rodrigues Pereira R, Kuik DJ, et al. Nephrotic syndrome in the Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011 Aug;26(8):1241-6.Full text  Abstract

18. Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008 May 24;336(7654):1185-9.Full text  Abstract

19. Vestergaard SV, Birn H, Jensen SK, et al. Twenty-four-year trends in incidence and mortality of nephrotic syndrome: a population-based cohort study. Epidemiology. 2023 May 1;34(3):411-20. Abstract

20. Trautmann A, Boyer O, Hodson E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023 Mar;38(3):877-919.Full text  Abstract

21. Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997 Nov;30(5):621-31. Abstract

22. Braden GL, Mulhern JG, O'Shea MH, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000 May;35(5):878-83. Abstract

23. Kolb A, Gallacher PJ, Campbell J, et al. A national registry study of patient and renal survival in adult nephrotic syndrome. Kidney Int Rep. 2021 Feb;6(2):449-59.Full text  Abstract

24. Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003 Mar;23(2):172-82. Abstract

25. Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24(9):717-32. Abstract

26. Jönsson A, Hellmark T, Segelmark M, et al. Causes of nephrotic syndrome in Sweden: the relevance of clinical presentation and demographics. Front Nephrol. 2023 Mar 17:3:1026864.Full text  Abstract

27. Mbakop C, DeVita MV, Wahl SJ, et al. Adult primary nephrotic syndrome trends by race: a diminished frequency of focal segmental glomerulosclerosis in non-black patients. Int Urol Nephrol. 2021 Apr;53(4):719-24. Abstract

28. Parikh RV, Tan TC, Fan D, et al. Population-based identification and temporal trend of children with primary nephrotic syndrome: the kaiser permanente nephrotic syndrome study. PLoS One. 2021 Oct 14;16(10):e0257674.Full text  Abstract

29. Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018 Nov;94(5):861-9. Abstract

30. Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis. 2003 Dec;42(6):1107-13. Abstract

31. Vivarelli M, Massella L, Ruggiero B, et al. Minimal change disease. Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-45.Full text  Abstract

32. Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006 Jun;69(12):2251-60.Full text  Abstract

33. Farruggia P, Trizzino A, Maringhini S, et al. Hodgkin lymphoma and nephrotic syndrome in childhood. Indian J Pediatr. 2010 Oct;77(10):1147-9. Abstract

34. Wenderfer SE. Viral-associated glomerulopathies in children. Pediatr Nephrol. 2015 Nov;30(11):1929-38.Full text  Abstract

35. De Vriese AS, Sethi S, Nath KA, et al. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol. 2018 Mar;29(3):759-74.Full text  Abstract

36. de Roij van Zuijdewijn C, van Dorp W, Florquin S, et al. Bisphosphonate nephropathy: a case series and review of the literature. Br J Clin Pharmacol. 2021 Sep;87(9):3485-91.Full text  Abstract

37. Hinkes BG, Mucha B, Vlangos CN, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007 Apr;119(4):e907-19. Abstract

38. Nieto-Gañán I, Iturrieta-Zuazo I, Rita C, et al. Revisiting immunological and clinical aspects of membranous nephropathy. Clin Immunol. 2022 Apr;237:108976.Full text  Abstract

39. Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7(suppl 1):64-71. Abstract

40. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009 Jul 2;361(1):11-21.Full text  Abstract

41. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011 Feb 17;364(7):689-90.Full text  Abstract

42. Ruggenenti P, Debiec H, Ruggiero B, et al. Anti-ohospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol. 2015 Oct;26(10):2545-58.Full text  Abstract

43. Kim YG, Choi YW, Kim SY, et al. Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy. Am J Nephrol. 2015;42(3):250-7. Abstract

44. Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020 Apr;22 Suppl 1:3-15.Full text  Abstract

45. Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl (2011). 2018 Jan;8(1):2-7.Full text  Abstract

46. Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004 Jan;27(suppl 1):S79-83.Full text  Abstract

47. Zeng YQ, Yang YX, Guan CJ, et al. Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021. BMC Endocr Disord. 2022 Jun 30;22(1):168.Full text  Abstract

48. Pham TT, Sim JJ, Kujubu DA, et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol. 2007;27(3):322-8. Abstract

49. García-Carro C, Vergara A, Bermejo S, et al. How to assess diabetic kidney disease progression? from albuminuria to GFR. J Clin Med. 2021 Jun 5;10(11):2505.Full text  Abstract

50. Correa-Rotter R, Naicker S, Katz IJ, et al. Demographic and epidemiologic transition in the developing world: role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease. Kidney Int Suppl. 2004 Nov;(92):S32-7. Abstract

51. Hobeika L, Hunt KJ, Neely BA, et al. Comparison of the rate of renal function decline in nonproteinuric patients with and without diabetes. Am J Med Sci. 2015 Dec;350(6):447-52. Abstract

52. Piccoli GB, Grassi G, Cabiddu G, et al. Diabetic kidney disease: a syndrome rather than a single disease. Rev Diabet Stud. 2015 Spring-Summer;12(1-2):87-109.Full text  Abstract

53. Real de Asúa D, Costa R, Galván JM, et al. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014 Oct 29:6:369-77.Full text  Abstract

54. Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013 Feb 20;8:31.Full text  Abstract

55. Scottish Paediatric Renal and Urology Network. Idiopathic nephrotic syndrome in children, management. Mar 2017 [internet publication].Full text

56. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol. 2011 Jul;31(4):341-8. Abstract

57. Salvadori M, Rosso G. Reclassification of membranoproliferative glomerulonephritis: identification of a new GN: C3GN. World J Nephrol. 2016 Jul 6;5(4):308-20.Full text  Abstract

58. Boyer O, Schaefer F, Haffner D, et al. Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group. Nat Rev Nephrol. 2021 Apr;17(4):277-89.Full text  Abstract

59. Park SJ, Shin JI. Complications of nephrotic syndrome. Korean J Pediatr. 2011 Aug;54(8):322-8.Full text  Abstract

60. Hilmanto D, Mawardi F, Lestari AS, et al. Disease-associated systemic complications in childhood nephrotic syndrome: a systematic review. Int J Nephrol Renovasc Dis. 2022 Feb 25:15:53-62.Full text  Abstract

61. Stabouli S, Chrysaidou K, Kupferman JC, et al. Neurological complications in childhood nephrotic syndrome: a systematic review. Eur J Paediatr Neurol. 2019 May;23(3):384-91. Abstract

62. Athanasopoulou D, Lionaki S, Skalioti C, et al. Drug-induced podocytopathies:report of four cases and review of the literature. Life (Basel). 2023 May 26;13(6):1264.Full text  Abstract

63. Harshman LA, Bartosh S, Engen RM. Focal segmental glomerulosclerosis: risk for recurrence and interventions to optimize outcomes following recurrence. Pediatr Transplant. 2022 Sep;26(6):e14307.Full text  Abstract

64. Yamamoto R, Imai E, Maruyama S, et al. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study. J Nephrol. 2022 May;35(4):1135-44. Abstract

65. Cavanaugh C, Perazella MA. Urine sediment examination in the diagnosis and management of kidney disease: core curriculum 2019. Am J Kidney Dis. 2019 Feb;73(2):258-72.Full text  Abstract

66. Sedlacek M, Schoolwerth AC. Images in clinical medicine. "Maltese crosses" in the nephrotic syndrome. N Engl J Med. 2007 Aug 23;357(8):806.Full text  Abstract

67. Bacchetta J, Juillard L, Cochat P, et al. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009 Apr;70(1):39-58. Abstract

68. Kidney Disease Improving Global Outcomes Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021 Oct;100(4S):1-276.Full text

69. Luciano RL, Moeckel GW. Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis. 2019 Mar;73(3):404-15.Full text  Abstract

70. Bobart SA, De Vriese AS, Pawar AS, et al. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int. 2019 Feb;95(2):429-38.Full text  Abstract

71. Stout LC, Kumar S, Whorton EB. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule. Hum Pathol. 1993 Jan;24(1):77-89. Abstract

72. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006 Dec;17(12):3458-71.Full text  Abstract

73. Bradwell AR, Carr-Smith HD, Mead GP, et al. Serum test for assessment of patients with Bence Jones myeloma. Lancet. 2003 Feb 8;361(9356):489-91. Abstract